Impact of the COVID-19 outbreak on hospitalizations and outcomes in patients with acute myocardial infarction in a Japanese Single Center.
Aged
Aged, 80 and over
COVID-19
Coronary Angiography
/ trends
Female
Hospital Mortality
/ trends
Hospitalization
/ trends
Humans
Incidence
Japan
/ epidemiology
Male
Middle Aged
Myocardial Infarction
/ diagnostic imaging
Patient Acceptance of Health Care
Percutaneous Coronary Intervention
/ trends
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Time-to-Treatment
/ trends
Treatment Outcome
Acute myocardial infarction
COVID-19 outbreak
Time from the symptom onset to admission
Journal
Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
15
12
2020
accepted:
12
03
2021
pubmed:
21
3
2021
medline:
26
8
2021
entrez:
20
3
2021
Statut:
ppublish
Résumé
There are a few Japanese data regarding the incidence and outcomes of acute myocardial infarction (AMI) after the coronavirus disease 2019 (COVID-19) outbreak. We retrospectively reviewed the data of AMI patients admitted to the Nihon University Itabashi Hospital after a COVID-19 outbreak in 2020 (COVID-19 period) and the same period from 2017 to 2019 (control period). The patients' characteristics, time course of admission, diagnosis, and treatment of AMI, and 30-day mortality were compared between the two period-groups for both ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI), respectively. The AMI inpatients decreased by 5.7% after the COVID-19 outbreak. There were no differences among most patient backgrounds between the two-period groups. For NSTEMI, the time from the symptom onset to admission was significantly longer, and that from the AMI diagnosis to the catheter examination tended to be longer during the COVID-19 period than the control period, but not for STEMI. The 30-day mortality was significantly higher during the COVID-19 period for NSTEMI (23.1% vs. 1.9%, P = 0.004), but not for STEMI (9.4% vs. 8.3%, P = 0.77). In conclusion, hospitalizations for AMI decreased after the COVID-19 outbreak. Acute cardiac care for STEMI and the associated outcome did not change, but NSTEMI outcome worsened after the COVID-19 outbreak, which may have been associated with delayed medical treatment due to the indirect impact of the COVID-19 pandemic.
Identifiants
pubmed: 33743048
doi: 10.1007/s00380-021-01835-w
pii: 10.1007/s00380-021-01835-w
pmc: PMC7980755
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1474-1483Informations de copyright
© 2021. Springer Japan KK, part of Springer Nature.
Références
Am J Emerg Med. 2017 Apr;35(4):589-593
pubmed: 28132793
Am J Emerg Med. 2021 Jun;44:192-197
pubmed: 33039221
Circ J. 2015;79(6):1255-62
pubmed: 25912696
Circ Cardiovasc Interv. 2020 Aug;13(8):e009413
pubmed: 32791953
Eur J Cardiothorac Surg. 2021 May 8;59(5):1096-1102
pubmed: 33394040
J Am Coll Cardiol. 2001 Jun 15;37(8):2053-8
pubmed: 11419887
Circulation. 1987 Jul;76(1):142-54
pubmed: 3109764
Circ J. 2006 Mar;70(3):217-21
pubmed: 16501282
J Am Heart Assoc. 2020 Nov 17;9(22):e018379
pubmed: 33023348
Heart. 2020 Dec;106(23):1812-1818
pubmed: 33023905
J Cardiol. 2018 Jul;72(1):33-41
pubmed: 29452763
Circulation. 2010 Feb 23;121(7):863-9
pubmed: 20142444
Ment Health Phys Act. 2020 Oct;19:100358
pubmed: 33072187
Cardiovasc Drugs Ther. 2021 Apr;35(2):215-229
pubmed: 33074525
Lancet. 2003 Jan 4;361(9351):13-20
pubmed: 12517460
Mayo Clin Proc Innov Qual Outcomes. 2020 Oct;4(5):506-510
pubmed: 33043274
N Engl J Med. 2001 Jun 21;344(25):1879-87
pubmed: 11419424
Eur Heart J. 2020 May 14;41(19):1852-1853
pubmed: 32297932
Curr Probl Cardiol. 2021 Mar;46(3):100693
pubmed: 33032817
Circ J. 2019 Apr 25;83(5):1085-1196
pubmed: 30930428
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
Curr Probl Cardiol. 2021 Mar;46(3):100715
pubmed: 33081992
Lancet. 2004 Sep 11-17;364(9438):953-62
pubmed: 15364186
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631